Clinical Trial Update: Trial of Calcineurin Inhibitor-Sparing Immunosuppression Regimen in Pediatric Liver Transplantation [Phase 4]

View source ↗

Summary

Phase 4 trial update on a calcineurin inhibitor-sparing immunosuppression regimen for pediatric liver transplantation; study terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• End-stage Liver Disease
• Renal Failure
• Renal Insufficiency

Snippet

Sponsor: Baylor College of Medicine | Conditions: End-stage Liver Disease, Renal Insufficiency | Phase 4 | Status: TERMINATED